IP Verse

Rapamycin Derivative For Treating Advanced Solid Tumours - EP3345602

PATENT ANALYSIS

Patent Details

Grant Date
Apr 6, 2022
Company
NOVARTIS AG
Oppositions

ETHYPHARM

GENERICS [UK] LIMITED

STADA ARZNEIMITTEL AG

More patents of Novartis Ag

EP3124018

EP3023095

EP3626270

Want to monitor this patent?

Feel free to send us a message here and we will get back to you